1887
  1. Home
  2. Eurosurveillance
  3. Volume 20, Issue 46, 19/Nov/2015
  4. Article
Research article Open Access
Like 0
Download

Abstract

We estimated the proportion of migrants from sub-Saharan Africa who acquired human immunodeficiency virus (HIV) while living in France. Life-event and clinical information was collected in 2012 and 2013 from a random sample of HIV-infected outpatients born in sub-Saharan Africa and living in the Paris region. We assumed HIV infection in France if at least one of the following was fulfilled: (i) HIV diagnosis at least 11 years after arrival in France, (ii) at least one negative HIV test in France, (iii) sexual debut after arrival in France. Otherwise, time of HIV infection was based on statistical modelling of first CD4+ T-cell count; infection in France was assumed if more than 50% (median scenario) or more than 95% (conservative scenario) of modelled infection times occurred after migration. We estimated that 49% of 898 HIV-infected adults born in sub-Saharan Africa (95% confidence interval (CI): 45–53) in the median and 35% (95% CI: 31–39) in the conservative scenario acquired HIV while living in France. This proportion was higher in men than women (44% (95% CI: 37–51) vs 30% (95% CI: 25–35); conservative scenario) and increased with length of stay in France. These high proportions highlight the need for improved HIV policies targeting migrants.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2015.20.46.30065
2015-11-19
2018-09-19
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2015.20.46.30065
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/20/46/eurosurv-20-30065-4.html?itemId=/content/10.2807/1560-7917.ES.2015.20.46.30065&mimeType=html&fmt=ahah

References

  1. Hamers FF, Downs AM. The changing face of the HIV epidemic in western Europe: what are the implications for public health policies? Lancet. 2004;364(9428):83-94.  https://doi.org/10.1016/S0140-6736(04)16594-X  PMID: 15234861 
  2. Del Amo J, Likatavičius G, Pérez-Cachafeiro S, Hernando V, González C, Jarrín I, et al. The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland: 1999-2006. Eur J Public Health. 2011;21(5):620-6.  https://doi.org/10.1093/eurpub/ckq150  PMID: 21051469 
  3. Cazein F, Lot F, Pillonel J, Le Strat Y, Sommen C, Pinget R, et al. (Discoveries of HIV seropositivity and AIDS: France, 2003-2012). Découvertes de séropositivité VIH et de sida: France, 2003-2012. Bull Epidémiologique Hebd.2014;9-10:154-62.
  4. Tron L, Lert F, Spire B, Dray-Spira RANRS-Vespa2 study group. Tobacco smoking in HIV-infected versus general population in france: heterogeneity across the various groups of people living with HIV. PLoS ONE. 2014;9(9):e107451.  https://doi.org/10.1371/journal.pone.0107451  PMID: 25202968 
  5. Institut national de la statistique et des études économiques (INSEE). Immigrés et descendants d’immigrés en France, édition 2012 [Immigrants and descendants of immigrants in France, edition 2012]. Paris: INSEE; 2012. French. Available from: http://www.insee.fr/fr/ffc/docs_ffc/ref/IMMFRA12_g_Flot1_pop.pdf
  6. Le Vu S, Le Strat Y, Barin F, Pillonel J, Cazein F, Bousquet V, et al. Population-based HIV-1 incidence in France, 2003-08: a modelling analysis. Lancet Infect Dis. 2010;10(10):682-7.  https://doi.org/10.1016/S1473-3099(10)70167-5  PMID: 20832367 
  7. Burns FM, Arthur G, Johnson AM, Nazroo J, Fenton KASONHIA collaboration group. United Kingdom acquisition of HIV infection in African residents in London: more than previously thought. AIDS. 2009;23(2):262-6.  https://doi.org/10.1097/QAD.0b013e32831c546b  PMID: 19098498 
  8. European Centre for Disease Prevention and Control (ECDC). ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe. Madrid: 3-4 October 2013; 2013. Available from: http://ec.europa.eu/health/sti_prevention/docs/ev_20131210_co08_en.pdf
  9. Rice BD, Elford J, Yin Z, Delpech VC. A new method to assign country of HIV infection among heterosexuals born abroad and diagnosed with HIV. AIDS. 2012;26(15):1961-6.  https://doi.org/10.1097/QAD.0b013e3283578b80  PMID: 22781226 
  10. Le Cœur S, Im-em W, Koetsawang S, Lelièvre É. Vulnérabilité et vie avec le VIH en Thaïlande : l'apport de l'approche biographique. [Living with HIV in Thailand: assessing vulnerability through a life-event history approach]. Population (Paris). 2005;60(4):551-68. French. https://doi.org/10.3917/pope.504.0473 
  11. Ndawinz JDA, Costagliola D, Supervie V. New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: results for France. AIDS. 2011;25(15):1905-13.  https://doi.org/10.1097/QAD.0b013e32834af619  PMID: 21811147 
  12. Supervie V, Ndawinz JDA, Lodi S, Costagliola D. The undiagnosed HIV epidemic in France and its implications for HIV screening strategies. AIDS. 2014;28(12):1797-804.  https://doi.org/10.1097/QAD.0000000000000270  PMID: 24681416 
  13. Ndawinz JDA, Anglaret X, Delaporte E, Koulla-Shiro S, Gabillard D, Minga A, et al. New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon. Bull World Health Organ. 2015;93(8):521-8.  https://doi.org/10.2471/BLT.14.147892  PMID: 26478609 
  14. Minga AK, Lewden C, Gabillard D, Bomisso GI, Toni TD, Emième AA, et al. CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters. AIDS. 2011;25(6):819-23.  https://doi.org/10.1097/QAD.0b013e32834625d3  PMID: 21412060 
  15. Thomas D, Luk W. Sampling from the multivariate Gaussian distribution using reconfigurable hardware. In: Field-programmable custom computing machines, 2007. FCCM 2007. 15th Annual IEEE Symposium, 23-25 April 2007. Available from: http://cas.ee.ic.ac.uk/people/dt10/research/thomas-07-multivariate-gaussian.pdf
  16. Lert F, Annequin M, Tron L, Aubrière C, Hamelin C, Spire B, et al. Situation sociale et état de santé des personnes vivant avec le VIH aux Antilles, en Guyane et à La Réunion en 2011. Premiers résultats de l’enquête ANRS-Vespa2. [Social situation and health status of people living with HIV in the Antilles, Guyana and Reunion in 2011. First results of the ANRS-Vespa2 investigation]. Bull Epidémiologique Hebd.2013;26-27:293-9. French.
  17. Ministère des affaires sociales et de la santé, Morlat P. Prise en charge médicale des personnes vivant avec le VIH. Recommandations du groupe d’experts. Rapport 2013 [Medical care for people living with HIV. Recommendations of the expert group. 2013 report]. Paris: Direction de l’information légale et administrative; 2013. French. Available from: http://www.sante.gouv.fr/IMG/pdf/Rapport_Morlat_2013_Mise_en_ligne.pdf
  18. Lucas E, Cazein F, Brunet S, Thierry D, Pillonel J, Lot F, et al. Types, groupes et sous-types de VIH diagnostiqués en France depuis 2003: données de huit années de surveillance. [Types, groups and subtypes of HIV diagnosed in France since 2003: data from eight years of surveilance]. Bull Épidémiologique Hebd. 2012;(46-47):533-7. French.
  19. Fenton KA, Mercer CH, McManus S, Erens B, Wellings K, Macdowall W, et al. Ethnic variations in sexual behaviour in Great Britain and risk of sexually transmitted infections: a probability survey. Lancet. 2005;365(9466):1246-55.  https://doi.org/10.1016/S0140-6736(05)74813-3  PMID: 15811458 
  20. Marsicano E, Lydié N, Bajos N. ‘Migrants from over there’ or ‘racial minority here’? Sexual networks and prevention practices among sub-Saharan African migrants in France. Cult Health Sex. 2013;15(7):819-35.  https://doi.org/10.1080/13691058.2013.785024  PMID: 23659520 
  21. Pailhé A, Robette N, Solaz A. Work and family over the life-course. A typology of French long-lasting couples using optimal matching. Longit Life Course Stud. 2013;4(3):196-217.
  22. Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, et al. Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa. Wilkinson RJ, editor. PLoS ONE. 2012;7(3):e32369.
  23. Laurent C, Bourgeois A, Faye MA, Mougnutou R, Seydi M, Gueye M, et al. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study. J Infect Dis. 2002;186(4):486-92.  https://doi.org/10.1086/341833  PMID: 12195375 
  24. Supervie V, Costagliola D. The spectrum of engagement in HIV care in France : strengths and gaps. 20th Conference on Retroviruses and Opportunistic Infections. Atlanta, March 2013. Abstract #:1030. 2013.
  25. Fakoya I, Álvarez-del Arco D, Woode-Owusu M, Monge S, Rivero-Montesdeoca Y, Delpech V, et al. A systematic review of post-migration acquisition of HIV among migrants from countries with generalised HIV epidemics living in Europe: mplications for effectively managing HIV prevention programmes and policy. BMC Public Health. 2015;15(1):561.  https://doi.org/10.1186/s12889-015-1852-9  PMID: 26085030 
Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Annabel++Desgr%C3%A9es-du-Lo%C3%BB&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Desgrées-du-Loû Annabel </a>, <a href="/search?value1=Julie+Pannetier&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pannetier Julie</a>, <a href="/search?value1=Andrainolo+Ravalihasy&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ravalihasy Andrainolo</a>, <a href="/search?value1=Anne+Gosselin&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gosselin Anne</a>, <a href="/search?value1=Virginie+Supervie&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Supervie Virginie</a>, <a href="/search?value1=Henri+Panjo&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Panjo Henri</a>, <a href="/search?value1=Nathalie+Bajos&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bajos Nathalie</a>, <a href="/search?value1=France+Lert&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lert France</a>, <a href="/search?value1=Nathalie+Lydi%C3%A9&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lydié Nathalie</a>, <a href="/search?value1=Rosemary+Dray-Spira&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Dray-Spira Rosemary</a>, <a href="/search?value1=The+Parcours+Study+Group5&option1=author&noRedirect=true" class="nonDisambigAuthorLink">The Parcours Study Group5</a></span>. Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013. <a href="/content/ecdc">Euro Surveill.</a> 2015;20(46):pii=30065. <a href="https://doi.org/10.2807/1560-7917.ES.2015.20.46.30065" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2015.20.46.30065</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 11 Feb 2015;&nbsp;&nbsp; <span class="generated">Accepted</span>: 07 Oct 2015 </span> </p>
/content/10.2807/1560-7917.ES.2015.20.46.30065
/content/10.2807/1560-7917.ES.2015.20.46.30065
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error